Dan Liang

Dan Liang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2021 in Reproduction
Verified
Journal Article
Closed access
PDF file
FXFenfen Xie
Fenfen Xie
JZJunhui Zhang
Junhui Zhang
MZMuxin Zhai
Muxin Zhai
YLYa-Jing Liu
Ya-Jing Liu
HHHui Hu
Hui Hu
YCYun-Xia Cao
Yun-Xia Cao
Emerging evidence has demonstrated that melatonin (MT) plays a crucial role in regulating mammalian reproductive functions. It has been reported that MT has a protective effect on polycystic ovary syndrome (PCOS). However, the protective mechanisms of MT remain poorly understood. This study aims to explore the effect of MT on ovarian function in PCOS and to elucidate the relevant molecular mechanisms in vivo and in vitro. We first analysed MT expression levels in the follicular fluid of PCOS patients. A significant reduction in MT expression levels was noted in PCOS patients. Intriguingly, reduced MT levels correlated with serum testosterone and inflammatory cytokine levels in follicular fluid. Moreover, we confirmed the protective function of MT through regulating autophagy in a DHEA-induced PCOS rat model. Autophagy was activated in the ovarian tissue of the PCOS rat model, whereas additional MT inhibited autophagy by increasing PI3K−-Akt pathway expression. In addition, serum-free testosterone, inflammatory and apoptosis indexes were reduced after MT supplementation. Furthermore, we also found that MT suppressed autophagy and apoptosis by activating the PI3K-Akt pathway in the DHEA-exposed human granulosa cell line KGN. Our study showed that MT ameliorated ovarian dysfunction by regulating autophagy in DHEA-induced PCOS via the PI3K-Akt pathway, revealing a potential therapeutic drug target for PCOS.

1 November 2021 in Mitochondrion
Verified
Journal Article
Closed access
QXQ.E. Xie
Q.E. Xie
MWM.Y. Wang
M.Y. Wang
ZCZ.P. Cao
Z.P. Cao
XDXin Du
Xin Du
DJD.M. Ji
D.M. Ji
YLYa-Jing Liu
Ya-Jing Liu

12 August 2025 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
SXSaijuan Xu
Saijuan Xu
DLDan Liang
Dan Liang
QWQiudao Wang
Qiudao Wang
YCYan Cheng
Yan Cheng
DXDa Xie
Da Xie
YWYuxuan Wu
Yuxuan Wu

30 July 2024 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
DLDan Liang
Dan Liang
RYRui Yan
Rui Yan
XLXin Long
Xin Long
DJDongmei Ji
Dongmei Ji
BSBing Song
Bing Song
FGFan Guo
Fan Guo
The conversion of DNA 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) by TET enzymes represents a significant epigenetic modification, yet its role in early human embryos remains largely unknown. Here we showed that the early human embryo inherited a significant amount of 5hmCs from an oocyte, which unexpectedly underwent de novo hydroxymethylation during its growth. Furthermore, the generation of 5hmC in the paternal genome after fertilization roughly followed the maternal pattern, which was linked to DNA methylation dynamics and regions of sustained methylation. The 5hmCs persisted until the eight-cell stage and exhibited high enrichment at OTX2 binding sites, whereas knockdown of OTX2 in human embryos compromised the expression of early lineage genes. Specifically, the depletion of 5hmC affected the activation of embryonic genes, which was further evaluated by ectopically expressing mouse Tet3 in human early embryos. These findings revealed distinct dynamics of 5hmC and unravelled its multifaceted functions in early human embryonic development.

25 July 2024 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
SDSi-Min Ding
Si-Min Ding
LSLing-Ge Shi
Ling-Ge Shi
FXFen Xing
Fen Xing
SCShuang-Shuang Cui
Shuang-Shuang Cui
HCHui-Ru Cheng
Hui-Ru Cheng
YLYa-Jing Liu
Ya-Jing Liu

12 December 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FXFen Xing
Fen Xing
MWMengyao Wang
Mengyao Wang
ZDZhiming Ding
Zhiming Ding
JZJunhui Zhang
Junhui Zhang
SDSimin Ding
Simin Ding
YLYa-Jing Liu
Ya-Jing Liu
Chemotherapeutics’ development has enhanced the survival rate of cancer patients; however, adverse effects of chemotherapeutics on ovarian functions cause fertility loss in female cancer patients. Cisplatin (CP), an important chemotherapeutic drug for treating solid tumors, has adversely affected ovarian function. Melatonin (MT) has been shown to have beneficial effects on ovarian function owing to its antioxidative function. In this research, an animal model was established to explore the effect of MT on CP-induced ovarian damage. Immunohistochemical analysis and Western blot were also used to explore its mechanism. This study reported that MT protects mouse ovaries from CP-induced damage. Specifically, MT significantly prevented CP-induced ovarian reserve decline by maintaining AMH and BMP15 levels. We also found that MT ameliorated CP-induced cell cycle disorders by up-regulating CDC2 expression, and inhibited CP-induced ovarian inflammation by decreasing IL-1β and IL-18 levels. Moreover, MT protected the ovary from CP-induced mitochondrial damage, as reflected by restoring mitochondria-related protein expression. Furthermore, CP caused ovarian apoptosis, as indicated by up-regulated BAX expression. MT was also shown to activate the MAPK pathway. Our results showed that MT could ameliorate ovarian damage induced by CP, implying that MT may be a viable alternative to preserve female fertility during CP chemotherapy.